Weekly recap

Insider trades and Congress trades, week of May 11–17, 2026

In the week of May 11–17, 2026, insiders filed 228 open-market purchases worth about $165M and 1,425 open-market sales; the largest purchase was $35.1M of Republic Services (RSG) by CASCADE INVESTMENT; members of Congress disclosed 9 purchases and 13 sales; 10 purchases stood out against the company's record since 2006.

By filing date, Monday to Sunday. Every line links to its SEC, House or Senate record. Public filings, not investment advice.

Purchases that stand out against 20 years of filings

Measured against every open-market trade the company's insiders filed since 2006. See all of them on the rare insider trades page.

Largest insider purchases

Largest insider sales

Congress trades disclosed

Members report a value range, not an exact amount; the trade can be up to 45 days older than its report.

Executives who announced they are leaving

  • Rani Therapeutics Holdings (RANI) · May 15, 2026

    “On May 12, 2026, Svai Sanford, the Company’s Chief Financial Officer, advised the Company that he will resign from his position following the appointment of his successor.” 8-K

  • Tandem Diabetes Care (TNDM) · May 15, 2026

    “On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.” 8-K

  • Volitionrx (VNRX) · May 15, 2026

    “On May 12, 2026, Mickie Henshall notified the Board of Directors (the “Board”) of VolitionRx Limited (the “Company”) of her decision not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).” 8-K

  • Agenus (AGEN) · May 15, 2026

    “On May 12, 2026, Austin Charette, Senior Director, Financial Reporting and Compliance and Principal Accounting Officer of Agenus Inc. (the "Company"), informed the Company he will be resigning effective May 29, 2026.” 8-K

  • Ventas (VTR) · May 15, 2026

    “On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc. (the “Separation Agreement”), pursuant to which Mr. Bulgarelli will receive a payment equal to…” 8-K

  • Quaker Chemical Corporation (KWR) · May 15, 2026

    “On May 12, 2026, Mr. Michael F. Barry, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”) notified the Company of his retirement from the Board, effective at the conclusion of the Board meeting on May 13, 2026.” 8-K

  • Clearway Energy, Inc. (Class C) (CWEN) · May 15, 2026

    “On May 15, 2026, Clearway Energy, Inc. (the “Company”) announced that Kevin P. Malcarney will retire from his position as Executive Vice President, General Counsel and Corporate Secretary of the Company, effective June 1, 2026 (the “Transition Date”).” 8-K

  • Energy Fuels (UUUU) · May 15, 2026

    “On May 11, 2026, Mr. David C. Frydenlund, previously Executive Vice President and Chief Legal Officer of Energy Fuels Inc. (the "Company"), transitioned into the role of Executive Vice President, Strategic Acquisitions and Financings and Special Counsel to the Chief Executive Officer, in connection with Mr. Frydenlund's planned retirement in October 2026 and in accordance with the general succession plan provided…” 8-K

The company's own words, from the opening sentence of its Form 8-K (Item 5.02).

5% stakes filed (Schedules 13D and 13G)

  • Charles W. Ergen filed an activist stake (13D) of 51.0% in EchoStar (ECHO)Filed May 15, 2026 · SEC
  • Felix J. Baker filed an activist stake (13D) of 15.6% in Incyte (INCY)Filed May 11, 2026 · SEC
  • T. Rowe Price Investment Management, Inc. reported a passive stake (13G) of 16.0% in PTC Inc. (PTC)Filed May 15, 2026 · SEC
  • Capital Research Global Investors reported a passive stake (13G) of 14.8% in International Paper (IP)Filed May 14, 2026 · SEC
  • Capital Research Global Investors reported a passive stake (13G) of 13.6% in Pinnacle West Capital (PNW)Filed May 14, 2026 · SEC
  • Cohen & Steers, Inc. reported a passive stake (13G) of 13.2% in BXP, Inc. (BXP)Filed May 15, 2026 · SEC
  • Capital World Investors reported a passive stake (13G) of 10.7% in Bunge Global (BG)Filed May 14, 2026 · SEC
  • Capital Research Global Investors reported a passive stake (13G) of 10.5% in Royal Caribbean Group (RCL)Filed May 14, 2026 · SEC

Largest federal contract awards

See the record behind any of these

Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.

Get OQRO ProOpen Atara Biotherapeutics free$9.99 a month, cancel anytime